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Background: Recent evidence has indicated an association between chronic cerebrospinal venous insufficiency
(CCSVI) and multiple sclerosis. Small internal jugular veins (IJVs) (with a cross-sectional area of less than 0.4 cm2)
have been previously described as difficult to catheterize, and their presence may potentially affect cerebrospinal
venous drainage. In this blinded extracranial color-Doppler study we had two principal aims: first, to assess
prevalence of CCSVI among Serbian MS patients compared to healthy controls; and second, to assess prevalence of
small IJVs (with a CSA ≤ 0.4 cm2) among MS patients and controls.
Methods: The sixty seven unrelated patients with clinical isolated syndrome (CIS), relapsing-remitting (RR),
secondary progressive (SP) and primary progressive (PP) multiple sclerosis and 21 healthy controls were examined
by high-resolution color-Doppler.
Results: The ultrasonographic criteria of CCSVI (according to Zamboni) were positive in 11.9% of the patients and
in none of the control subjects. The CCSVI-positive patients had significantly longer disease durations and were
significantly more disabled (measured by their Expanded Disability Status Scale (EDSS) and Multiple Sclerosis
Severity Score (MSSS) scores), but after adjustment for gender and disease duration, CCSVI was not an independent
risk factor for multiple sclerosis severity. The small IJVs were found in 28.4% of the patients and 28.6% of the
controls. The patients with small IJVs were associated with decreased venous outflow from the brain and presented
with longer disease durations and significantly higher EDSS and MSSS scores compared to patients without small IJVs.
A multivariate logistic regression analysis adjusted for gender and disease duration showed that small IJV is an
independent factor associated with multiple sclerosis severity (EDSS ≥6) (adjusted OR = 8.9, 95% CI: 1.8-45.6, p = 0.007).
Among patients with small IJVs the 36.84% were also CCSVI positive.
Conclusions: Both, CCSVI and small IJVs seem to influence or follow MS severity, but only small IJVs turned out to be
an independent factor in this study. Thus, small IJVs with restricted outflow, which might be aspects of CCSVI different
from the criteria originally described by Zamboni, emerge as a cofactor in the multifactorial pathophysiology of
multiple sclerosis.
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Table 1 Characteristics of patients with MS and controls
Parameter Patients
(n = 67)
Controls
(n = 21)
p
Female/male (%) 48.0/52.0 33.3/66.7 ns*
Age (years ± SD) 35.7 ± 9.5 32.9 ± 10.1 ns‡
Age at onset (years ± SD) 27.6 ± 7.5 -
Disease course, n (%) -
CIS 5 (7.5)
RR 41 (61.2)
CP 21 (31.3)
Disease duration (years ± SD) 9.1 ± 6.3 -
EDSS (mean ± SD) 3.9 ± 2.1 -
3.8§
MSSS (mean ± SD) 5.4 ± 2.7 - 0.000002#,$
in RR group 4.6 ± 2.0
in CP group 7.4 ± 1.3
CIS: clinically isolated syndrome; RR: relapsing-remitting; CP: chronic
progressive (including secondary progressive and primary progressive); EDSS:
Expanded Disability Status Scale; MSSS: Multiple Sclerosis Severity Score; * χ2 ;
§ median; ‡ ANOVA; # ANOVA for RR vs. CP patients; $ Scheffe’s post-hoc test
for RR vs. CP patients; the values represent the means ± S.D.
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Multiple sclerosis (MS) is a chronic autoimmune disease
of the central nervous system (CNS). This disease is char-
acterized by inflammation, demyelination and axonal in-
jury, which leads to the formation of sclerotic plaques [1].
The complex etiology and heterogeneity of clinical out-
comes associated with MS have led investigators to search
for new risk factors and etiological explanations for the
development and progression of this disease. One of the
proposed factors was chronic cerebrospinal venous insuf-
ficiency (CCSVI) [2], which is characterized by anomalies
of the main extracranial cerebrospinal (CS) venous routes
(internal jugular veins (IJVs), the vertebral veins (VVs) and
the azygos vein (AZY). The conflicting results about asso-
ciation between CCSVI (and its clinical correlates) and
MS have been presented [2-6] and the question emerged
if it is a primary or secondary condition to MS. It is be-
lieved that noninvasive venous echo-color ultrasound and
transcranial (ECD/TCD) Doppler is useful for revealing
the presence of outflow disturbances and morphological
abnormalities in IJVs and VVs [7,8]. Using differing meth-
odologies, all of these studies showed that IJV stenosis, de-
fined either as a cross-sectional area (CSA) ≤ 0.3 cm2 or
as a local CSA reduction of ≥50% [2,4,9], is one of the
most frequently observed CCSVI criteria in patients with
MS. IJV asymmetries were first observed in healthy sub-
jects. Approximately one-third of healthy adults (34%)
have one IJV that is significantly smaller than the other
[10]. In 2001, prior to the research linking CCSVI to MS,
Lichtenstein et al. examined IJV asymmetry among inten-
sive care unit patients undergoing catheterization of the
IJV as a routine procedure [11]. These researchers ob-
served that 23% of IJVs were small, with a CSA ≤ 0.4 cm2,
which could complicate the catheterization procedure
[11]. However, neither them nor others have examine
whether an IJV CSA ≤ 0.4 could be associated with MS,
either as a primary or secondary phenomenon. There
were two principal aims of this study: first, to assess
prevalence of CCSVI among Serbian MS patients com-
pared to healthy controls; and second, to assess preva-
lence of small IJVs (with a CSA ≤ 0.4 cm2) among MS
patients and controls.
Methods
Ethics statement
The Ethical Committee of the Military Medical Academy
(MMA), Belgrade, Serbia, approved this study. Each par-
ticipant gave written informed consent to participate in
the study.
Study design
This cross-sectional study aims to assess prevalence of
CCSVI and prevalence of small IJVs (with a CSA ≤ 0.4 cm2)
among MS patients and controls from Serbia and toevaluate its correlation with clinical parameters of disease
severity. The sixty seven unrelated patients with clinical iso-
lated syndrome (CIS), relapsing-remitting (RR), secondary
progressive (SP) and primary progressive (PP) multiple
sclerosis, of Serbian origin, were recruited from the Neur-
ology Clinic of the MMA, Serbia. All patients except CIS
fulfilled the criteria for clinically definite MS [12] and the
course of the disease was determined based on clinical data
[13]. The chronic progressive (CP) group included the SP
and PP MS patients. Disease severity was estimated using
the Multiple Sclerosis Severity Score (MSSS) [14], which
represents the Expanded Disability Status Scale (EDSS) [15]
corrected for disease duration. Global MSSS values
were calculated according to clinical data at the same
time when ultrasound measurements were performed.
The patients included in the study were never receiving
a disease modifying therapy. On the basis of EDSS
value the patients were divided into those with lower
functional disability (EDSS < 6) and those with high dis-
ability (EDSS ≥ 6). The patient group consisted of 32 fe-
males and 35 males, of mean age of 35.7 ± 9.5 years and
mean disease age at onset 27.6 ± 7.5 years (Table 1).
The control group consisted of 7 female and 14 male
healthy volunteers of mean age of 32.9 ± 10.1 years. The
controls were of the same ethnical origin as the MS
patients.
Ultrasound measurements
All patients and controls were examined using 7.5 MHz
linear transducer for extracranial measurements and
2.5 MHz probe connected to the same ultrasound
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Toshiba, Tokyo, Japan). Ultrasound assessments were
performed in an identical fashion in patients and controls.
The posture of the individual being examined by Doppler
is crucial in determining the main route of cerebral out-
flow. Each subject was investigated in both supine and sit-
ting positions (0° and 90°). All participants were examined
by the same ultrasonographer who was blinded to the
case–control selection. It is hard to be blinded to the pa-
tients with severe neurological disability, thus during the
study the ultrasonographer had to examine ten more pa-
tients with high neurological disability caused by diseases
other than MS (Amyotrophic lateral sclerosis, Stroke,
Myasthenia gravis, Miller Fisher Syndrome), blinded to
the patients diagnosis. This way we provided the blinded
measurements even for the severe patients.
Assessment of CCSVI
Both, patients and controls were examined for CCSVI
according to five criteria proposed by Zamboni [2].
These criteria were: 1- Reflux (time > 0.88 seconds) in
the IJVs and/or in the VVs (vertebral veins) in sitting
and supine position; 2- Reflux (time > 0.5 seconds) in the
deep cerebral veins; 3- Stenosis. We assessed the pres-
ence of IJV stenosis by manual measuring the cross-
sectional area (CSA) of the IJV using a transverse
section, above bulbus up to 15 mm above the cricoid
cartilage, at the middle level (J2), adjacent to the thyroid
gland. The CSA and the flow direction were measured at
the end of the expiratory phase or during a short period of
apnea after a normal exhalation [16]. The CSA ≤0.3 cm2
in the recumbent position was defined as a stenosis; 4-
Flow not detected by Doppler in IJVs and/or VVs; 5-
Reverted postural control of the main cerebral venous
outflow pathways: a missing increase of IJV CSA in the su-
pine position. The presence of at least two of Zamboni’s
criteria in the same individual was considered positive for
evidence of CCSVI.
Assessment of small IJV
The IJV was defined as small IJV if the regional
narrowing of IJV, ≤ 0.4 cm2, above bulbus up to 15 mm
above the cricoid cartilage, at the middle level (J2), adja-
cent to the thyroid gland was detected. We took into ac-
count the CSA values in healthy subjects in the
midcervical area [17]. If a subject demonstrated only re-
gional narrowing of the IJV, with CSA ≤ 0.4 cm2, he was
also considered as a small IJV positive. All individuals
were examined in sitting and supine positions using the
transversal access. The operator used minimal pressure
over the skin to prevent compressing the vein and
thereby affecting the measurement. Also, a thick layer of
ultrasonic gel was used to avoid excessive pressure on
the patient’s neck, which may change the shape anddimension of the IJV. The examination was repeated in
randomly selected 7 patients after two weeks, and the
results were 100% concordant.Assessment of blood volume flow (BVF)
It was previously suggested that additional assessment of
hemodynamic parameters provides sufficient informa-
tion to make a diagnosis of venous outflow obstruction
[4]. As recommended we measured the BVF by Doppler
flowmetry using the software included in the package of
the ultrasound equipment (Powervision 6000, Toshiba,
Tokyo, Japan). For the IJVs and VVs, the time averaged
blood volume was analyzed according to protocol previ-
ously described [4]. Measurements were obtained at an
identical site in supine and upright body position, the
same way in patients and controls. The subjects were
asked to briefly hold their breath after an exhalation,
and measurements were obtained during such an epi-
sode of apnea. To avoid false positive results, we made
particular efforts to avoid a compression of the vein by
the transducer or neck muscles. The measurement was
performed at the level of the thyroid gland for the IJVs
and at the level of C5-C6 for VVs [17]. The blood flow
was measured in both, IJVs and VVs separately and then
calculated into total blood flow in sitting and supine
position. The difference between the total BVF in supine
and sitting position (Δ BVF) was calculated in both pa-
tients and controls as suggested [4,18].Statistical analysis
Statistical analysis was performed using Statistica soft-
ware package (Version 5, StatSoft, 1997). Differences in
frequency distribution between the studied groups were
estimated by chi-square (χ2) test and confirmed by
Fisher's exact test. Means of normally distributed con-
tinuous variables were compared by unpaired t-test or
ANOVA. For variables with significantly skewed distri-
bution, comparisons were done by nonparametric
Kruskal-Wallis ANOVA. The sensitivity and specificity,
AUC and CI, were determined using ROC-tool designed
by Acomed statistik (Leipzig, Germany). The maximum
likelihood estimation was applied in the analysis of the
association between functional disability defined as cat-
egorical variable (0, EDSS < 6 or 1, EDSS ≥ 6) and small
IJV, expressed in terms of OR and 95% confidence inter-
val (CI). In multivariate regression analysis, which
included the factors that were significantly different in-
between groups and kept covariates in the model if the p
of the model was <0.001. Differences with two-tailed
alpha-probability p ≤ 0.05 were considered significant. To
correct for multiple comparisons, a conservative Type I
error level of 0.01 was used to assess significance of chi-
square test and logistic regression results. Statistical power
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was calculated using the PS (v3.0.43) [19].Results
The characteristics of the patients and controls are
presented in Table 1. Demographic characteristics of the
MS patients and the controls were not significantly differ-
ent (Table 1). Chronic progressive (CP) patients (including
secondary progressive, SP and primary progressive, PP)
had significantly higher Multiple Sclerosis Severity
Scores (MSSS) compared to relapse-remitting (RR) pa-
tients (p = 0.000002).CCSVI in MS patients and controls
Out of 67 MS patients, 8 (11.9%) were positive for
CCSVI according to the criteria described in the Experi-
mental Methods. None of the controls were CCSVI posi-
tive. The prevalence of CCSVI according to different
clinical courses of MS (CIS, RR and CP) is shown in
Table 2. CCSVI was significantly more prevalent among
the chronic progressive patients (CP) compared to the
non-progressive patients (CIS and RR) (23.8% vs. 6.5%,
two-tailed χ2 p = 0.043). CCSVI was also significantly
more common among the patients with severe MS
(EDSS ≥ 6) (n = 7 were CCSVI positive out of 25 patients
with EDSS ≥ 6, p = 0.002, Figure 1) and was associated
with a significantly higher MSSS (p = 0.008) (Table 2).
Multivariate logistic regression analysis adjusted for gen-
der and disease duration revealed that CCSVI was not a
significant independent predictor of MS disease severity
(EDSS ≥ 6) (p = 0.06). However, disease duration was anTable 2 Characteristics of patients with MS according to CCSV
Parameter Patients (n =67)
CCSVI- CCSV
n (%) 59 (88.1) 8 (11.
Female/male (%) 49.2/50.8 50.0/50
Age at onset (years ± SD) 27.5 ± 7.2 29.1 ±
Disease duration (years ± SD) 8.4 ± 5.9 14.4 ±
Disease course, n (%)
CIS 5 (8.5) 0
RR 38 (64.4) 3 (37.
CP 16 (27.1) 5 (62.
Total 59 (100) 8 (100
MSSS (mean ± SD) 5.2 ± 2.2 7.4 ± 1
EDSS (mean ± SD) 3.6 ± 2.0 5.85 ±
CCSVI: chronic cerebrospinal venous insufficiency; CIS: clinically isolated syndrome;
progressive and primary progressive); MSSS: Multiple Sclerosis Severity Score; EDSS:
SD; ns: non-significant.independent predictor of MS disease severity (OR = 1.3,
95% CI: 1.1-1.6; p = 0.0003).Small IJV in MS patients and controls
We found that 28.4% (n = 19) of the patients and 28.6%
(n = 6) of the controls had at least one small internal
jugular vein (CSA ≤ 0.4 cm2) (Table 3). The majority of
the small IJVs were detected on the left side in both the
patients and the controls (66.1% and 68.1%, respectively).
Among the patients with small IJVs the 36.84% were also
CCSVI-positive. The prevalence of small IJVs differed
significantly according to different clinical courses of
MS (p = 0.0002), with the highest prevalence in the CP
group (68.4%, all SP). Small IJVs were significantly
more common among the patients with severe MS
(EDSS ≥ 6) (n = 15 were sIJV positive out of 25 patients
with EDSS ≥ 6, p = 0.00001, Figure 1). The mean MSSS
was significantly higher among the patients with small
IJVs (p = 0.002, Table 3). Multivariate logistic regression
analysis adjusted for gender, disease duration and the
side where the small IJV was located, has revealed that
the patients with small IJVs were 8.9-fold more likely to
develop a severe form of MS (EDSS ≥ 6) (adjusted OR =
8.9, 95% CI: 1.8-45.6, p = 0.007). The power of the study
to detect an association between small IJVs and EDSS ≥ 6
with OR = 8.9 was 89% (calculated retrospectively with an
increased stringency of the Type I error level at 0.01). We
also performed a multivariate regression with MSSS as
a clinical parameter of disease severity (the cut-off
value was taken as the median). Patients with MSSS ≥
5.4 (median) were considered to have severe MS. Again,
the results revealed a significant adjusted associationI status
Controls (n =21) p
I+ CCSVI- CCSVI+
9) 21(100) 0 (0) 0.1*
.0 33.3/66.7 0/0 ns*
9.7 - 0.6#
6.5 - 0.01#
- 0.12*
5)
5)
)
.4 - 0.008#
1.8 0.007#
RR: relapsing-remitting; CP: chronic progressive (including secondary
Expanded Disability Status Scale; * χ2; # ANOVA; values represent the means ±
Figure 1 Prevalence of CCSVI and small IJV as a function of EDSS (EDSS < 6 vs. EDSS ≥ 6). Shows prevalence of A) CCSVI, CCSVI + n = 7/25
with EDSS≥ 6, (*χ2, p = 0.002), and B) small IJV, sIJV + n = 15/ 25 MS patients with EDSS≥ 6 (*χ2, p = 0.00001) in MS patients categorized by
functional disability (EDSS < 6 vs. EDSS≥ 6). EDSS: Expanded Disability Status Scale; CCSVI: chronic cerebrospinal venous insufficiency; small IJV:
small internal jugular vein.
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(OR = 4.7, 95% CI: 1.4-16.5, p = 0.012).
Blood volume flow
The mean total bilateral blood volume flow (BVF)
(mL/min) in the IJVs and VVs with the subject in either a
supine or sitting position was not significantly different
between the patients vs. the controls (supine: 639.17 ±
306.05 vs. 548.47 ± 223.16, respectively, p = 0.26; sitting:
492.55 ± 232.79 vs. 411.95 ± 208.63, respectively, p = 0.22)
(Figure 2A). The mean value of difference in the BVF be-
tween the supine and upright position (Δ BVF) was not
significantly different between patients with MS and
controls (p = 0.8). Furthermore, the BVF was not sig-
nificantly different between the small IJV-positive and -
negative patients (supine: 531.39 ± 346.15 vs. 656.20 ±
259.55, respectively, p = 0.08, sitting: 423.27 ± 223.46 vs.
497.15 ± 229.61, respectively, p = 0.21). The total BVF
was not significantly lower among the CCSVI-positiveTable 3 Characteristics of patients with MS according to smal
Parameter Patients (n = 67)
small IJV- small IJV+
n (%) 48 (71.6) 19 (28.4)
Female/male (%) 45.8/54.2 52.6/47.4
Age at onset (years ± SD) 27.4 ± 7.1 28.0 ± 8.7
Disease duration(years ± SD) 7.2 ± 5.4 13.8 ± 6.0
Disease course, n (%)
CIS 5 (10.4) 0 (0)
RR 35(72.9) 6 (31.6)
CP 8 (16.7) 13 (68.4)
Total 48 (100) 19 (100)
MSSS (mean ± SD) 4.8 ± 2.1 6.8 ± 2.2
EDSS (mean ± SD) 3.2 ± 1.8 5.6 ± 1.9
Small IJV: small internal jugular vein (CSA ≤ 0.4 cm2); CIS: clinically isolated syndrom
progressive and primary progressive); MSSS: Multiple Sclerosis Severity Score; EDSS:
means ± SD; ns: non-significant.compared to the CCSVI-negative MS patients (supine:
439.71 ± 320.96 vs. 664.21 ± 300.18, respectively, p =
0.07; sitting: 404.00 ± 161.11 vs. 481.24 ± 233.74, re-
spectively, p = 0.46) (Figure 2B). The mean BVF mea-
sured in the smaller IJV in all the patients was
significantly decreased in the small IJV-positive com-
pared to small IJV-negative patients (supine: 108.69 ±
96.06 vs. 209.56 ± 109.76, respectively, p = 0.001; sitting:
70.40 ± 68.67 vs. 129.00 ± 109.66, respectively, p = 0.03)
(Figure 3A). The patients with severe MS (EDSS ≥ 6)
had decreased BVF in the smaller IJV compared to the pa-
tients with EDSS < 6, a finding that was significant only in
the supine position (142.56 ± 118.81 vs. 202.66 ± 106.91,
respectively, p = 0.04) (Figure 3B). The sensitivity and spe-
cificity of BVF, in the smaller IJV in the supine position, as
a predictor of either small IJV or EDSS ≥ 6, exhibited
values below 50% (AUC: 0.25, SE: 0.06 and 95% CI: 0.15-
0.38; and AUC: 0.32, SE: 0.07 and 95% CI: 0.2-0.45,
respectively).l IJV status
Controls (n = 21) p
small IJV- small IJV+
15 (71.2) 6 (28.8) ns*
40/60 16.7/83.3 ns*, ns*
- 0.8#
0.00004#
- 0.0002*
- 0.002#
0.00003#
e; RR: relapsing-remitting; CP: chronic progressive (including secondary
Expanded Disability Status Scale; * χ2; # ANOVA; the values represent the
Figure 2 Total bilateral blood volume flow (BVF). Scatterplot of the total BVF (mL/min) relative to the mean BVF among A) patients with MS
and controls, p = 0.26; B) CCSVI-positive and CCSVI-negative MS patients, p = 0.07.
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In this study, we investigated the possibility of a causal
association between CCSVI and MS, and small IJVs and
MS, relationships that had not been previously examined
in a South-Eastern European population. Neither CCSVI
nor sIJVs prevalence was significantly different between
patients with MS and controls. The main findings of the
study were that both CCSVI and small IJVs seem to in-
fluence or follow MS severity. For the first time, in this
study, the small IJVs were revealed as an independent
factor associated with MS severity.
A subset (11.9%) of MS patients fulfilled at least two cri-
teria for CCSVI. The CCSVI-positive patients presented
with significantly longer durations of MS, and their EDSS
and MSSS scores were significantly higher than those of
the CCSVI-negative patients. Prevalence of CCSVI was
higher among the chronic progressive patients (SP and
PP) compared to non-progressive ones. This finding is in
line with two recent studies in which patients with the
progressive form of MS had a significantly higher CCSVI
prevalence [3,20]. In accordance with these studies [3,20],
we did not find a significant independent association be-
tween CCSVI and MS disease severity. Several studies on
patients with clinically definite MS have reported that overFigure 3 Total bilateral blood volume flow (BVF) in the smaller IJV of
BVF in the smaller IJV in the supine position among A) small IJV-positive M
patients with EDSS < 6 and EDSS ≥ 6, p = 0.04*.50% of these patients were CCSVI-positive [2,3,7,21],
whereas others have found an absolute lack of a positive
correlation [4,22]. However, the findings in the controls
have been more homogenous. We did not find two or
more CCSVI criteria among our control subjects, similar
to others [4,9]. The main hypothesis supported by our
data and by the results of the largest published studies
[3,23] is that CCSVI does not have a primary causative
role in MS but instead plays a contributing role or is a
consequence of the disease and long MS duration.
There are weaknesses in this and other studies, which
are mainly attributable to the methodological ap-
proaches employed. Extracranial color-Doppler high-
resolution examination, which we used in this study,
has been proposed as the most appropriate method to
observe dynamic changes in venous outflow [24]. How-
ever, a large, recent study using catheter venography
demonstrated a prevalence of pathologies in specific
veins of up to 81.7% [23], much higher than the levels
detected by Doppler. It has been suggested that
Doppler can detect the competence of the IJV valve,
the cross-sectional area in relation to a change in pos-
ture, duplex-derived flowmetry and anomalous morph-
ology [24], but it is likely that there are other methodsMS patients. Scatterplot of the BVF (mL/min) relative to the mean
S patients and small IJV-negative MS patients, p = 0.001*; B) MS
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abnormalities. Thus, we must be cautious in drawing
conclusions because there is a possibility that we were
unable to detect all venous pathologies, both in the pa-
tients and the controls. Although it has recently been
suggested that Doppler has limited diagnostic value for
diagnosing venous morphological changes [25], others
claim that the inter-rater reproducibility supports its
use for diagnostic purposes in multicenter studies
[8,26]. Ultrasound technology, which is widely used in
this field, is promoted by the revised protocol for CCSVI
screening [27] and is particularly advantageous due to its
noninvasive nature. The methodological heterogeneity of
detection of venous morphological changes might, at least
in part, explain different conclusions of the previous
studies.
Another possible limitation is the use of standard
CCSVI criteria. Five ultrasound criteria were proposed
by the founders of the CCSVI hypothesis [2], but these
have yet to be validated against a criterion standard [28].
For the third criterion, we defined IJV stenosis as CSA ≤
0.3 cm2 [2]. Initially, the cutoff for stenosis was defined
as a local CSA reduction of ≥50% [9], a threshold that
was adopted by other researchers [4]. In the same year,
the same group proposed a stenosis reference value of a
CSA ≤ 0.3 cm2 [2], which was again accepted by other
researchers [22]. This reference value (CSA ≤ 0.3) arose
somehow from the original proposal of a CSA ≤ 0.4 cm2
as the cutoff for small veins that are inadequate for
catheterization [11]. Discrepancies in definition of sten-
osis have been previously discussed [22]. Nevertheless,
some discrepancies between the studies could also be
linked to the anatomical level of CSA measurement
[2-4,6]. In the present study, the sonographer insonated
the IJV at all levels (J1, J2 and J3) and measured the
CSA at the middle level (J2), adjacent to the thyroid
gland, as proposed in the revised protocol [27]. These is-
sues should be resolved by the updated protocol [27],
which is much more precise than the previous definition
of the CCSVI criteria.
In addition to CCSVI, we investigated the relationship
between small IJVs (CSA ≤ 0.4 cm2) and MS. This is the
first study to examine this potential association. Simi-
larly to CCSVI, the prevalence of small IJVs was not dif-
ferent among the MS patients compared to the controls;
however, small IJVs were significantly more common
among the patients with progressive form of the disease.
The most important finding was that small IJV repre-
sents an independent factor associated with MS severity.
It has been suggested that venous malformations may
have a genetic etiology, and both environmental and
genetic factors could play a role in venous pathophysi-
ology [29,30]. Asymmetries and inborn anatomical dif-
ferences have been observed in the truncular venoussystem [31,32], particularly during catheterization/inter-
ventional procedures in different groups of patients
[11,33-36]. A narrowing of IJVs with a CSA < 0.4 cm2,
which are defined as small veins, was observed in 23% of
IJVs in different cases admitted to the intensive care unit
[11]. In our study, 28% of both MS patients and controls
were found to be small IJV-positive, which is in line with
previous studies. Majority of the small IJVs were
detected on the left side, both in MS patients and the con-
trols, similar to findings in a general population of adult
outpatients [37] and in the majority of CCSVI lesions [23].
However, a possibility exists that some vein narrowing
could be caused by muscular compression [38] or an
asymmetric pattern of intracranial sinuses [39].
The EDSS and MSSS scores were significantly higher
among small IJV-positive patients compared to those
presenting with normal veins. Our results are in agree-
ment with a recent study that has revealed longer dis-
ease durations and higher EDSS scores in the group of
MS patients with >80% jugular narrowing compared to
the group with less narrowing [40]. We found a signifi-
cantly higher prevalence of the patients with EDSS ≥ 6 in
the small IJV-positive group. EDSS ≥6 is a stringent cut-
off value, but we chose this criterion because, according
to the Kurtzke scale [15], an EDSS of 6–10 indicates se-
vere disease (the patient requires support to walk).
Nonetheless, we also performed a multivariate regression
and used the MSSS as a clinical parameter of disease se-
verity (with the cutoff at the median). The results con-
firmed a significant independent association between the
presence of small IJVs and disease severity. It is difficult
to compare our results to those of the others, since no
other trials have investigated small IJVs or even IJV seg-
mental stenosis as a single parameter potentially associ-
ated with MS. A higher prevalence of small IJVs in
chronic progressive patients (68.4%) is in line with previ-
ous finding that IJV stenosis is more frequent among SP
and PP compared to RR patients [2]. An association be-
tween late-stage MS and venous stenosis has also been
observed [41]. Similarly, in our study MS patients with
small IJVs had longer disease duration. Taken together,
these results suggest that both subtypes of truncular IJV
malformation (IJV stenosis and small IJVs) may influence
MS severity.
The BVF data certainly provide a comprehensive ana-
lysis of venous outflow obstruction. As suggested by
others [4], we included the BVF measurement to improve
evaluation of hemodynamic effects of any suspected
cerebrocervical venous congestion. The total BVF of the
subjects in the supine position in our study was similar to
that reported previously [42]. However, according to one
suggested interpretation of the AUC (area under the
curve) [43], the BVF in the IJV in this study was a poor
predictor of either the presence of small IJVs or MS
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question in the BVF assessment. One of the shortcomings
in this study was the measurement of the BVF only in J2
level, which might be the explanation of the absence of
difference between patients and controls. According to re-
cent study it should be measured at J1 where it is the
highest, in both patients and controls [16]. The others
performed the measurement of IJV BVF as apical as pos-
sible in the upper region of the neck [4]. Besides, BVF is a
parameter that exhibits interindividual variations; there-
fore, the relatively small number of measurements in our
study may account for the lack of significance of this
result.
The IJVs are considered to be the main pathways of
cerebral blood drainage. The IJVs shows physiological
variations of its diameter. The wide anatomical variabil-
ity and varying degrees of jugular and non-jugular ven-
ous drainage have been shown in the healthy volunteers
[42]. The pathophysiological significance of changes in
IJVs, either in its anatomy or function in blood drainage
has not been completely understood. It has recently
been suggested that both cardiovascular autonomic ner-
vous system dysfunctions and dysfunctions of the norad-
renergic neurons in the cerebral venous system could
result in an impairment of cerebral autoregulation and
in reduction of vascular tone, which would in turn
promote venous closure [44]. Also, IJVs drain the
blood, which was shown to contain metabolically ac-
tive substances. It was suggested that early activation
of the l-arginine/NO pathway, which accompanies the
release of vasoactive peptides happens in the migraine
[45]. It was detected by analyzing the internal jugular
venous blood of patients. Further studies should inves-
tigate metabolic changes in the brain by analysis of
blood drained through jugular pathways, as it could
shed new light on the both, MS associated changes and
possible pathophysiological role of small IJVs in MS.
According to our results and recent finding on mag-
netic resonance venography [40], small IJVs could have
pathophysiological significance in MS. Still, the measur-
able hemodynamic effect were detected only in vessels
with narrowing >80%, the group with the highest fre-
quency of secondary progressive MS patients [40]. The
small IJVs could be partially the primary phenomenon, as
they are present in control group, but also could be in part
the secondary one that develops as a consequence of MS.
Further studies are needed to replicate these results and
to resolve whether small IJVs are a cause or a consequence
of MS.
Conclusions
We conclude that the presence of small IJVs (CSA ≤
0.4 cm2) may be an independent cofactor in the multi-
factorial mechanism of MS pathogenesis. The presenceof small IJVs is associated with the increased probability
of a severe clinical course of the disease. This finding
may be important for the future treatment of MS, but it
first must be validated and replicated by other studies,
especially with severely disabled patients.
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